The Top Line

Misconduct and the future of neurodegenerative disease research


Listen Later

 Last month, the NIH announced that it had found evidence of research misconduct by Eliezer Masliah, M.D., the head of the neuroscience division at the National Institute on Aging. The NIH announcement coincided with the Sept. 26 publication of an investigation by Science, finding that 132 papers published by Masliah appear to contain manipulated images. 

In this week’s episode of “The Top Line,” Fierce Biotech’s Darren Incorvaia dives into this issue with Matthew Schrag, M.D., Ph.D., a neuroscientist who contributed to the dossier outlining Masliah’s misconduct.

To learn more about the topics in this episode:  

NIH neuroscience leader committed research misconduct, agency investigation finds

See omnystudio.com/listener for privacy information.

...more
View all episodesView all episodes
Download on the App Store

The Top LineBy Fierce Life Sciences

  • 4
  • 4
  • 4
  • 4
  • 4

4

11 ratings


More shows like The Top Line

View all
Planet Money by NPR

Planet Money

30,646 Listeners

Motley Fool Money by The Motley Fool

Motley Fool Money

3,218 Listeners

Exchanges by Goldman Sachs

Exchanges

978 Listeners

Odd Lots by Bloomberg

Odd Lots

1,873 Listeners

WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,638 Listeners

a16z Podcast by Andreessen Horowitz

a16z Podcast

1,092 Listeners

The Readout Loud by STAT

The Readout Loud

325 Listeners

Wall Street Breakfast by Seeking Alpha

Wall Street Breakfast

1,037 Listeners

Behind the Money by Financial Times

Behind the Money

228 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

6,093 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

34 Listeners

Economics Explained by Economics Explained

Economics Explained

145 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

18 Listeners

The Markets by Goldman Sachs

The Markets

77 Listeners

WSJ's Take On the Week by The Wall Street Journal

WSJ's Take On the Week

146 Listeners